Table 2.
Clinical presentation of post-COVID-19 condition symptoms
| Symptoms | 1st observation-2022 (n = 522) |
2nd observation-2024 (n = 465) |
||
|---|---|---|---|---|
| Frequency | Percentage | Frequency | Percentage | |
| Common Symptoms | ||||
| Breathlessness or Dyspnea | 347 | (66.5%) | 369 | (79.4%) |
| Cough | 93 | (17.8%) | 63 | (13.5%) |
| Fatigue | 235 | (45.0%) | 415 | (89.2%) |
| Chest pain | 57 | (10.9%) | 203 | (43.7%) |
| Myalgia | 73 | (13.9%) | 302 | (64.9%) |
| Arthralgia | 63 | (12.1%) | 317 | (68.2%) |
| Headache | 73 | (13.9%) | 345 | (74.2%) |
| Abdominal Pain | 07 | (1.3%) | 80 | (17.2%) |
| Ear pain | 26 | (4.9%) | 07 | (1.5%) |
| Concentration | 26 | (4.9%) | 294 | (63.2%) |
| Memory Loss | 37 | (7.1%) | 275 | (59.1%) |
| Planning Problems | 18 | (3.4%) | 177 | (38.1%) |
| Anxiety | 54 | (10.3%) | 324 | (69.7%) |
| Depression | 61 | (11.7%) | 194 | (41.7%) |
| PTSD | 01 | (0.2%) | 269 | (57.8%) |
| Dizziness | 26 | (4.9%) | 141 | (30.3%) |
| Sleep Disturbance | 55 | (10.5%) | 163 | (35.1%) |
| Fever | 66 | (12.6%) | 213 | (45.8%) |
| Skin Rash | 06 | (1.1%) | 151 | (32.5%) |
| Novel Symptoms in Respondents | ||||
| Diarrhea | - | 170 | (36.6%) | |
| Smell Problems | - | 201 | (43.2%) | |
| Hair Loss | - | 184 | (39.6%) | |
| Taste Alteration | - | 242 | (52.0%) | |
| Weight Loss | - | 84 | (18.1%) | |
| Visual Problems | - | 127 | (27.3%) | |
| Sore Throat | - | 62 | (13.3%) | |
| Tinnitus | - | 89 | (19.1%) | |
| Brain Fog | - | 77 | (16.6%) | |